Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities.

AIMS Injection drug use is a major risk factor for HIV and hepatitis infections. Whereas programs to prevent new infections have focused on HIV, they have generally neglected hepatitis B and C. This study was designed to examine the interrelationships among HIV and hepatitis knowledge, risky drug preparation and injection practices, and participation in syringe exchange programs (SEPs). DESIGN Surveys of injection drug users (IDUs) collected data on socio-demographics, medical history, drug use and injection practices, and HIV- and hepatitis-related knowledge. SETTING Inner-city US neighborhoods in Chicago, IL, Hartford, CT and Oakland, CA. PARTICIPANTS The study population was a convenience sample of 493 IDUs recruited using street outreach and snowball sampling strategies. MEASUREMENTS HIV and hepatitis knowledge, injection-related risks for virus transmission, associations between the two, and with SEP use. FINDINGS HIV knowledge was significantly higher than hepatitis knowledge among SEP customers and non-customers alike. Elevated hepatitis knowledge was associated with a history of substance abuse treatment, hepatitis infection, hepatitis B vaccination and injection practices that reduced contact with contaminated blood or water but not with SEP use. SEP customers were consistently less likely to engage in risk behaviors, with the notable exception of safely staunching blood postinjection. CONCLUSION Increased hepatitis awareness among IDUs is necessary for reducing hepatitis transmissions. Although SEPs continue to effectively disseminate HIV prevention messages-as evidenced by lowered risk behaviors among their customers-they must do more to prevent hepatitis transmissions.

[1]  C. Trautwein,et al.  Treatment of acute hepatitis C with interferon alfa-2b. , 2001, The New England journal of medicine.

[2]  D. D. Des Jarlais,et al.  Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program. , 2001, American journal of public health.

[3]  B. Walker,et al.  Hepatitis C virus infection. , 2001, The New England journal of medicine.

[4]  T. Wright,et al.  Acute hepatitis C , 2001, Hepatology.

[5]  B. Edlin,et al.  The effect of syringe exchange use on high-risk injection drug users: a cohort study , 2000, AIDS.

[6]  S. Tortu,et al.  Trends in injection risk behaviors in a sample of New York City injection drug users: 1992-1995. , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[7]  N. Weiss,et al.  Syringe exchange and risk of infection with hepatitis B and C viruses. , 1999, American journal of epidemiology.

[8]  B. Edlin,et al.  Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[9]  A. Leshner.  HIV prevention with drug using populations. Current status and future prospects. , 1998, Public health reports.

[10]  R. Needle,et al.  HIV prevention with drug-using populations--current status and future prospects: introduction and overview. , 1998, Public health reports.

[11]  J Normand,et al.  Outreach-based HIV prevention for injecting drug users: a review of published outcome data. , 1998, Public health reports.

[12]  R Brookmeyer,et al.  Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[13]  Douglas D. Heckathorn,et al.  Respondent-driven sampling : A new approach to the study of hidden populations , 1997 .

[14]  P. Lurie,et al.  An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA , 1997, The Lancet.

[15]  R. Booth,et al.  The prevalence of additional injection-related HIV risk behaviors among injection drug users. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[16]  S. Holmberg,et al.  The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. , 1996, American journal of public health.

[17]  D. Vlahov,et al.  Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. , 1996, American journal of public health.

[18]  J. Watters,et al.  Reliability of Self-Reported HIV Risk Behaviors of Drug Users , 1995 .

[19]  R. Curtis,et al.  Self-reports of HIV risk behavior by injecting drug users: are they reliable? , 1995, Addiction.

[20]  Lana D. Harrison,et al.  The Validity of Self-Reported Data on Drug Use , 1995 .

[21]  Mark E. Johnson,et al.  Reliability of Drug Users' Self-Reported HIV Risk Behaviors and Validity of Self-Reported Recent Drug Use , 1994 .

[22]  J. Watters.  Trends in Risk Behavior and HIV Seroprevalence in Heterosexual Injection Drug Users in San Francisco, 1986–1992 , 1994, Journal of acquired immune deficiency syndromes.

[23]  E H Kaplan,et al.  A method for evaluating needle exchange programmes. , 1994, Statistics in medicine.

[24]  J. Watters.  Historical perspective on the use of bleach in HIV/AIDS prevention. , 1994, Journal of acquired immune deficiency syndromes.

[25]  E H Kaplan,et al.  A circulation theory of needle exchange. , 1994, AIDS.

[26]  L. J. Short,et al.  Risk of occupational infection with blood-borne pathogens in operating and delivery room settings. , 1993, American journal of infection control.

[27]  R. Coutinho,et al.  A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam , 1993, European Journal of Epidemiology.

[28]  D. Vlahov,et al.  Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. , 1993, Addiction.

[29]  D. Vlahov,et al.  Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. , 1990, American journal of epidemiology.

[30]  H. Margolis,et al.  The Changing Epidemiology of Hepatitis B in the United States: Need for Alternative Vaccination Strategies , 1990 .

[31]  P. Biernacki,et al.  TARGETED SAMPLING: OPTIONS FOR THE STUDY OF HIDDEN POPULATIONS , 1989 .

[32]  T. S. Jones,et al.  Prevalence of HIV infection among intravenous drug users in the United States. , 1989, JAMA.

[33]  R. Chaisson,et al.  Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. , 1987, American journal of public health.

[34]  D. Shine,et al.  Intravenous drug abusers and the acquired immunodeficiency syndrome (AIDS). Demographic, drug use, and needle-sharing patterns. , 1985, Archives of internal medicine.

[35]  D. Vlahov,et al.  The effectiveness of needle exchange programs: A review of the science and policy , 2001 .

[36]  A. Widell,et al.  Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program. , 2000, Scandinavian journal of infectious diseases.

[37]  H. Margolis,et al.  Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. , 1999, American journal of public health.

[38]  M. Alter,et al.  The importance of preventing hepatitis C virus infection among injection drug users in the United States. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[39]  N. Haigwood,et al.  Humoral immunity to HIV, SIV, and SHIV. , 1998, AIDS.

[40]  T. S. Jones,et al.  HIV risk behaviors associated with the injection process: multiperson use of drug injection equipment and paraphernalia in injection drug user networks. , 1998, Substance use & misuse.

[41]  L. Metsch,et al.  Parenteral transmission of HIV among injection drug users: assessing the frequency of multiperson use of needles, syringes, cookers, cotton, and water. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[42]  J. Watters,et al.  HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. , 1998, American journal of public health.

[43]  R. Heimer,et al.  Syringe use and reuse: effects of syringe exchange programs in four cities. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[44]  D. Vlahov,et al.  Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions. , 1994, Epidemiologic reviews.

[45]  J. Watters,et al.  Drug-use profiles, race, age, and risk of HIV infection among intravenous drug users in San Francisco. , 1991, The International journal of the addictions.

[46]  R. Booth,et al.  Intravenous drug users and AIDS: risk behaviors. , 1991, The American journal of drug and alcohol abuse.

[47]  R. Pickens,et al.  HIV infection and AIDS risk behaviors among intravenous drug users entering methadone treatment in selected U.S. cities. , 1991, Journal of acquired immune deficiency syndromes.

[48]  Thomas F. Babor,et al.  Validity of self-reports in applied research on addictive behaviors: Fact or fiction? , 1990 .

[49]  D. Vlahov,et al.  Perspectives on infection with HIV-1 among intravenous drug users. , 1988, Psychopharmacology bulletin.

[50]  Wiebel Ww.  Combining ethnographic and epidemiologic methods in targeted AIDS interventions: the Chicago model. , 1988 .